VistaGen: Positive Data Leads To Catalysts In 2024 And Beyond (NASDAQ:VTGN) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
In this piece, we will take a look at the 11 most promising psychedelic stocks according to hedge funds. If you want to skip our overview of the psychedelic industry and the latest news, then you can take a look at the 5 Most Promising Psychedelic Stocks. The ability to use chemicals to alter one’s […]
/PRNewswire/ The neuropathy pain treatment market is expected to grow by USD 5.84 billion from 2023 to 2028. In addition, the momentum of the market will.
Jefferies Financial Group upgraded shares of Vistagen Therapeutics (NASDAQ:VTGN – Free Report) from a hold rating to a buy rating in a research report report published on Thursday morning, Marketbeat reports. They currently have $15.00 price objective on the stock. VTGN has been the topic of a number of other research reports. William Blair restated […]